Skip to main content
PPN WorldPPN World

PPN World · Archive

Reserved for subscribers

This release sits in the PPN World archive. Subscribers read the full wire as it lands — 80+ newswires, 190+ countries, searchable back through the archive, with alerts on the subjects they track.

  • Every release, the moment it crosses — not a daily digest
  • Search and filter the full archive, not the last 24 hours
  • Instant alerts on saved searches

PPN World — real-time press release intelligence.

Biocon obtient un avis favorable du CHMP pour son biosimilaire du pertuzumab, une première dans le cadre de la nouvelle approche clinique pour l'approbation des biosimilaires de l'EMA · Commercial newswire · PPN World